{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:08:47Z","timestamp":1793225327094,"version":"4.5.0"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Interstitial lung disease (ILD) is a major pulmonary complication of autoimmune rheumatic diseases (ARD) and a leading contributor to long-term morbidity and mortality. Although ARDs share underlying immune dysregulation, the onset, radiologic phenotype, and clinical course of ILD vary substantially across individual diseases. Consequently, early detection and structured risk stratification at baseline and during follow-up have become essential elements of care for patients at risk of ARD-related ILD.<\/jats:p>\n                  <jats:p>This review examines the principles and emerging strategies for early identification of ARD-related ILD, emphasizing the role of systematic clinical assessment, high-resolution computed tomography, and longitudinal pulmonary function evaluation in detecting early lung involvement. We discuss how radiologic patterns, functional measures, and serological profiles contribute to prognostic classification in different autoimmune contexts, with particular focus on the early identification of patients at risk of rapid ILD progression. Disease-specific ILD patterns are reviewed across major autoimmune conditions\u2014including systemic sclerosis, idiopathic inflammatory myopathies, primary Sj\u00f6gren\u2019s syndrome, mixed connective tissue disease, systemic lupus erythematosus, rheumatoid arthritis, and anti-neutrophil cytoplasmic antibody-associated vasculitis\u2014each characterized by distinct risk factors, distinct imaging findings, and divergent prognostic trajectories. Finally, we highlight emerging approaches to risk stratification, including integrated models that combine clinical, radiologic, and serological domains to mitigate the risk of disease progression and guide monitoring strategies.<\/jats:p>\n                  <jats:p>Overall, current evidence supports a precision-medicine framework for ARD-related ILD, in which early recognition and individualized assessment of progression risk are crucial to improving outcomes and informing therapeutic decision-making.<\/jats:p>","DOI":"10.1186\/s12931-026-03538-0","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T03:25:19Z","timestamp":1770348319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Early detection and risk stratification in autoimmune-related interstitial lung disease: a state-of-the-art review"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6383-8236","authenticated-orcid":false,"given":"Paolo","family":"Delvino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Alberto","family":"Scir\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Bondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Puccetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Trentanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Zanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Luppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"issue":"10354","key":"3538_CR1","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0140-6736(22)01052-2","volume":"400","author":"M Wijsenbeek","year":"2022","unstructured":"Wijsenbeek M, Suzuki A, Maher TM. Interstitial lung diseases. Lancet. 2022;400(10354):769\u201386. https:\/\/doi.org\/10.1016\/S0140-6736(22)01052-2.","journal-title":"Lancet"},{"issue":"5","key":"3538_CR2","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00408-020-00383-w","volume":"198","author":"N Jeganathan","year":"2020","unstructured":"Jeganathan N, Sathananthan M. Connective tissue disease-related interstitial lung disease: prevalence, patterns, predictors, prognosis, and treatment. Lung. 2020;198(5):735\u201359. https:\/\/doi.org\/10.1007\/s00408-020-00383-w.","journal-title":"Lung"},{"issue":"Suppl 124","key":"3538_CR3","first-page":"221","volume":"38","author":"M Sebastiani","year":"2020","unstructured":"Sebastiani M, Manfredi A, Vacchi C, et al. Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis. Clin Exp Rheumatol. 2020;38(Suppl 124):221\u201331.","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"3538_CR4","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/nrrheum.2014.149","volume":"10","author":"AU Wells","year":"2014","unstructured":"Wells AU, Denton CP. Interstitial lung disease in connective tissue disease - mechanisms and management. Nat Rev Rheumatol. 2014;10(12):728\u201339. https:\/\/doi.org\/10.1038\/nrrheum.2014.149.","journal-title":"Nat Rev Rheumatol"},{"key":"3538_CR5","doi-asserted-by":"publisher","unstructured":"Antoniou KM, Distler O, Gheorghiu AM, et al. ERS\/EULAR clinical practice guidelines for connective tissue diseases associated interstitial lung disease. Ann Rheum Dis. https:\/\/doi.org\/10.1016\/j.ard.2025.08.021.\u00a0Published online September 3, 2025. S0003-4967(25)04320-1.","DOI":"10.1016\/j.ard.2025.08.021"},{"issue":"11","key":"3538_CR6","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3899\/jrheum.171314","volume":"45","author":"Y Levi","year":"2018","unstructured":"Levi Y, Israeli-Shani L, Kuchuk M, Epstein Shochet G, Koslow M, Shitrit D. Rheumatological assessment is important for interstitial lung disease diagnosis. J Rheumatol. 2018;45(11):1509\u201314. https:\/\/doi.org\/10.3899\/jrheum.171314.","journal-title":"J Rheumatol"},{"issue":"8","key":"3538_CR7","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","volume":"76","author":"O Kowal-Bielecka","year":"2017","unstructured":"Kowal-Bielecka O, Fransen J, Avouac J, et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis. 2017;76(8):1327\u201339. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209909.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3538_CR8","doi-asserted-by":"publisher","first-page":"e201","DOI":"10.1016\/S2665-9913(24)00058-4","volume":"6","author":"A Lescoat","year":"2024","unstructured":"Lescoat A, Khanna D, Kuwana M, Allanore Y, Matucci-Cerinic M. Pre-scleroderma and new opportunities for preventive medicine \u2013 Authors\u2019 reply. Lancet Rheumat. 2024;6(4):e201. https:\/\/doi.org\/10.1016\/S2665-9913(24)00058-4.","journal-title":"Lancet Rheumat"},{"issue":"3","key":"3538_CR9","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S2213-2600(19)30480-1","volume":"8","author":"A Perelas","year":"2020","unstructured":"Perelas A, Silver RM, Arrossi AV, Highland KB. Systemic sclerosis-associated interstitial lung disease. Lancet Respir Med. 2020;8(3):304\u201320. https:\/\/doi.org\/10.1016\/S2213-2600(19)30480-1.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"3538_CR10","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1164\/rccm.201903-0563CI","volume":"201","author":"D Khanna","year":"2020","unstructured":"Khanna D, Tashkin DP, Denton CP, Renzoni EA, Desai SR, Varga J. Etiology, risk factors, and biomarkers in systemic sclerosis with interstitial lung disease. Am J Respir Crit Care Med. 2020;201(6):650\u201360. https:\/\/doi.org\/10.1164\/rccm.201903-0563CI.","journal-title":"Am J Respir Crit Care Med"},{"key":"3538_CR11","doi-asserted-by":"publisher","unstructured":"Cottin V, Brown KK. Interstitial lung disease associated with systemic sclerosis (SSc-ILD). Respir Res. 2019;20(1). https:\/\/doi.org\/10.1186\/s12931-019-0980-7.","DOI":"10.1186\/s12931-019-0980-7"},{"key":"3538_CR12","doi-asserted-by":"publisher","unstructured":"Distler O, Assassi S, Cottin V, et al. Predictors of progression in systemic sclerosis patients with interstitial lung disease. Eur Respir J. 2020;55(5). https:\/\/doi.org\/10.1183\/13993003.02026-2019.","DOI":"10.1183\/13993003.02026-2019"},{"issue":"1","key":"3538_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.chest.2023.08.013","volume":"165","author":"P Moinzadeh","year":"2024","unstructured":"Moinzadeh P, Bonella F, Oberste M, et al. Impact of systemic sclerosis-Associated interstitial lung disease with and without pulmonary hypertension on survival: A large cohort study of the German network for systemic sclerosis. Chest. 2024;165(1):132\u201345. https:\/\/doi.org\/10.1016\/j.chest.2023.08.013.","journal-title":"Chest"},{"issue":"8","key":"3538_CR14","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1002\/acr.25347","volume":"76","author":"SR Johnson","year":"2024","unstructured":"Johnson SR, Bernstein EJ, Bolster MB, et al. 2023 American college of rheumatology (ACR)\/American college of chest physicians (CHEST) guideline for the screening and monitoring of interstitial lung disease in people with systemic autoimmune rheumatic diseases. Arthritis Care Res. 2024;76(8):1070\u201382. https:\/\/doi.org\/10.1002\/acr.25347.","journal-title":"Arthritis Care Res"},{"issue":"10","key":"3538_CR15","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1164\/rccm.201903-0486OC","volume":"200","author":"AM Hoffmann-Vold","year":"2019","unstructured":"Hoffmann-Vold AM, Fretheim H, Halse AK, et al. Tracking impact of interstitial lung disease in systemic sclerosis in a complete nationwide cohort. Am J Respir Crit Care Med. 2019;200(10):1258\u201366. https:\/\/doi.org\/10.1164\/rccm.201903-0486OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"3538_CR16","doi-asserted-by":"publisher","first-page":"e0310892","DOI":"10.1371\/journal.pone.0310892","volume":"19","author":"FG Amorim","year":"2024","unstructured":"Amorim FG, Dos Santos ER, Yuji Verrastro CG, Kayser C. Quantitative chest computed tomography predicts mortality in systemic sclerosis: a longitudinal study. PLoS ONE. 2024;19(9):e0310892. https:\/\/doi.org\/10.1371\/journal.pone.0310892.","journal-title":"PLoS ONE"},{"key":"3538_CR17","doi-asserted-by":"publisher","unstructured":"Schniering J, Maciukiewicz M, Gabrys HS, et al. Computed tomography-based radiomics decodes prognostic and molecular differences in interstitial lung disease related to systemic sclerosis. Eur Respir J. 2022;59(5). https:\/\/doi.org\/10.1183\/13993003.04503-2020.","DOI":"10.1183\/13993003.04503-2020"},{"issue":"3","key":"3538_CR18","doi-asserted-by":"publisher","first-page":"e0213444","DOI":"10.1371\/journal.pone.0213444","volume":"14","author":"M Occhipinti","year":"2019","unstructured":"Occhipinti M, Bosello S, Sisti LG, et al. Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels. PLoS ONE. 2019;14(3):e0213444. https:\/\/doi.org\/10.1371\/journal.pone.0213444.","journal-title":"PLoS ONE"},{"key":"3538_CR19","doi-asserted-by":"publisher","unstructured":"Stock CJW, Nan Y, Fang Y, et al. Deep-learning CT imaging algorithm to detect usual interstitial pneumonia pattern in patients with systemic sclerosis-associated interstitial lung disease: association with disease progression and survival. Rheumatology (Oxford). 2024. https:\/\/doi.org\/10.1093\/rheumatology\/keae571. ((Stock C.J.W.; Kokosi M.; Kouranos V.; George P.M.; Chua F.; Jenkins G.R.; Wells A.U.; Renzoni E.A.) Interstitial Lung Disease Unit, Royal Brompton and Harefield Hospitals, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, United Kingdom).","DOI":"10.1093\/rheumatology\/keae571"},{"issue":"6","key":"3538_CR20","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/art.40815","volume":"71","author":"M Elhai","year":"2019","unstructured":"Elhai M, Hoffmann-Vold AM, Avouac J, et al. Performance of candidate serum biomarkers for systemic sclerosis\u2013associated interstitial lung disease. Arthritis Rheum. 2019;71(6):972\u201382. https:\/\/doi.org\/10.1002\/art.40815.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"3538_CR21","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1002\/art.42491","volume":"75","author":"AS Jee","year":"2023","unstructured":"Jee AS, Stewart I, Youssef P, et al. A composite serum biomarker index for the diagnosis of systemic sclerosis\u2013associated interstitial lung disease: a multicenter, observational cohort study. Arthritis Rheum. 2023;75(8):1424\u201333. https:\/\/doi.org\/10.1002\/art.42491.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"3538_CR22","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1093\/rheumatology\/keae110","volume":"63","author":"MJS Parker","year":"2024","unstructured":"Parker MJS, Jee AS, Hansen D, et al. Multiple serum biomarkers associate with mortality and interstitial lung disease progression in systemic sclerosis. Rheumatology. 2024;63(11):2981\u20138. https:\/\/doi.org\/10.1093\/rheumatology\/keae110.","journal-title":"Rheumatology"},{"issue":"10","key":"3538_CR23","doi-asserted-by":"publisher","first-page":"e0311357","DOI":"10.1371\/journal.pone.0311357","volume":"19","author":"M d\u2019Alessandro","year":"2024","unstructured":"d\u2019Alessandro M, Cameli P, Cotton CV, et al. Panel of serum biomarkers for differential diagnosis of idiopathic interstitial lung disease and interstitial lung disease-secondary to systemic autoimmune rheumatic disease. PLoS ONE. 2024;19(10):e0311357. https:\/\/doi.org\/10.1371\/journal.pone.0311357.","journal-title":"PLoS ONE"},{"issue":"4","key":"3538_CR24","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/art.43051","volume":"77","author":"S Hoa","year":"2025","unstructured":"Hoa S, Berger C, Lahmek N, et al. Characterization of incident interstitial lung disease in late systemic sclerosis. Arthritis Rheum. 2025;77(4):450\u20137. https:\/\/doi.org\/10.1002\/art.43051.","journal-title":"Arthritis Rheum"},{"key":"3538_CR25","doi-asserted-by":"publisher","unstructured":"Lei L, Ma Z, Ma X et al. An Observational Study on the Clinical Characteristics and Prognosis of Patients with Interstitial Lung Disease Secondary to Dermatomyositis and Antisynthetase Syndrome. Intl J Rheumatol. 2024;2024. https:\/\/doi.org\/10.1155\/2024\/9679944. ((Lei L., leiling1972@aliyun.com; Ma Z., 19460932@qq.com; Ma X., 1426418438@qq.com; Pan D., dongmei-gx@sr.gxmu.edu.cn; Chen Z., chzhrui@126.com; Qin F., qinfang-997@163.com; Dong F., 540076105@qq.com) Department of Rheumatology and Immunology, The First Affiliated Hospital of Guangxi Medical University, Guangxi Province, Nanning, China).","DOI":"10.1155\/2024\/9679944"},{"key":"3538_CR26","doi-asserted-by":"publisher","unstructured":"Mariampillai K, Pastissier A, Stojkovic T et al. Autoimmune myopathies: P.307 Evaluation of ACR\/EULAR criteria for myositis diagnosis and classification in care pathways of a French neuromuscular reference centre. Neuromuscular Disord. 2020;30. https:\/\/doi.org\/10.1016\/j.nmd.2020.08.304.\u00a0((Mariampillai K.; Pastissier A.; Stojkovic T.; Eymard B.; Bassez G.; Allenbach Y.; Benveniste O.) H\u00f4pital Piti\u00e9 Salp\u00eatri\u00e8re, Paris, France).","DOI":"10.1016\/j.nmd.2020.08.304"},{"key":"3538_CR27","doi-asserted-by":"publisher","unstructured":"Zanatta E, Cocconcelli E, Castelli G, et al. Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort. RMD Open. 2023;9(3). https:\/\/doi.org\/10.1136\/rmdopen-2023-003121.","DOI":"10.1136\/rmdopen-2023-003121"},{"key":"3538_CR28","doi-asserted-by":"publisher","unstructured":"Niu Y, Liu S, Qiu Q, et al. Increased serum level of IL-6 predicts poor prognosis in anti-MDA5-positive dermatomyositis with rapidly progressive interstitial lung disease. Arthritis Res Ther. 2024;26(1). https:\/\/doi.org\/10.1186\/s13075-024-03415-5.","DOI":"10.1186\/s13075-024-03415-5"},{"key":"3538_CR29","doi-asserted-by":"publisher","unstructured":"Kurasawa K, Arai S, Taniguchi-Namiki Y et al. Pulmonary and serum cytokine profiles of patients with anti-ARS and anti-MDA5 antibodies. J Autoimmun. 2025;151. https:\/\/doi.org\/10.1016\/j.jaut.2025.103374.\u00a0((Kurasawa K., kurasawa@dokkyomed.ac.jp; Arai S.; Taniguchi-Namiki Y.; Komatsu S.; Shimizu A.; Hasegawa A.; Hiyama T.; Miyao T.; Tanaka A.; Owada T.; Arima M.; Maezawa R.; Ikeda K.) Department of Rheumatology, Dokkyo Medical University, Tochigi, Mibu, Japan).","DOI":"10.1016\/j.jaut.2025.103374"},{"issue":"1","key":"3538_CR30","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/rheumatology\/keab305","volume":"61","author":"W Wu","year":"2021","unstructured":"Wu W, Xu W, Sun W, et al. Forced vital capacity predicts the survival of interstitial lung disease in anti-MDA5 positive dermatomyositis: a multi-centre cohort study. Rheumatology (Oxford). 2021;61(1):230\u20139. https:\/\/doi.org\/10.1093\/rheumatology\/keab305.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"3538_CR31","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/art.42308","volume":"75","author":"L Xu","year":"2023","unstructured":"Xu L, You H, Wang L, et al. Identification of three different phenotypes in Anti-Melanoma differentiation-Associated gene 5 Antibody-Positive dermatomyositis patients: implications for prediction of rapidly progressive interstitial lung disease. Arthritis Rheumatol. 2023;75(4):609\u201319. https:\/\/doi.org\/10.1002\/art.42308.","journal-title":"Arthritis Rheumatol"},{"key":"3538_CR32","doi-asserted-by":"publisher","first-page":"733599","DOI":"10.3389\/fmed.2021.733599","volume":"8","author":"Y Li","year":"2021","unstructured":"Li Y, Li Y, Wang Y, et al. A clinical risk model to predict rapidly progressive interstitial lung disease incidence in dermatomyositis. Front Med (Lausanne). 2021;8:733599. https:\/\/doi.org\/10.3389\/fmed.2021.733599.","journal-title":"Front Med (Lausanne)"},{"key":"3538_CR33","doi-asserted-by":"publisher","unstructured":"Pettorossi F, Fontana G, Bracalenti M, et al. ABS0916\u2005Factors associated with ILD, ICU admission and mortality in patients with anti-MDA5\u2009+\u2009dermatomyositis: results from two italian cohorts. Ann Rheum Dis. 2025;84:1697-1698. https:\/\/doi.org\/10.1016\/j.ard.2025.06.1133.\u00a0((Pettorossi F.; Bracalenti M.; Di Gregorio A.; Brischigliaro L.; Moccaldi B.; Depascale R.; Zanatta E.; Zen M.; Doria A.; Iaccarino L.) University of Padua, Rheumatology Unit, Department of Medicine, DIMED, Padua, Italy).","DOI":"10.1016\/j.ard.2025.06.1133"},{"issue":"2","key":"3538_CR34","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.autrev.2012.06.006","volume":"12","author":"B Hervier","year":"2012","unstructured":"Hervier B, Devilliers H, Stanciu R, et al. Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity. Autoimmun Rev. 2012;12(2):210\u20137. https:\/\/doi.org\/10.1016\/j.autrev.2012.06.006.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"3538_CR35","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1093\/rheumatology\/kex021","volume":"56","author":"I Pinal-Fernandez","year":"2017","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Huapaya JA, et al. A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies. Rheumatology (Oxford). 2017;56(6):999\u20131007. https:\/\/doi.org\/10.1093\/rheumatology\/kex021.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"3538_CR36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/rheumatology\/kes311","volume":"52","author":"O Palm","year":"2013","unstructured":"Palm O, Garen T, Berge Enger T, et al. Clinical pulmonary involvement in primary sjogren\u2019s syndrome: prevalence, quality of life and mortality\u2013a retrospective study based on registry data. Rheumatology (Oxford). 2013;52(1):173\u20139. https:\/\/doi.org\/10.1093\/rheumatology\/kes311.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"3538_CR37","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","volume":"87","author":"M Ramos-Casals","year":"2008","unstructured":"Ramos-Casals M, Solans R, Rosas J, et al. Primary Sj\u00f6gren syndrome in spain: clinical and Immunologic expression in 1010 patients. Med (Baltim). 2008;87(4):210\u20139. https:\/\/doi.org\/10.1097\/MD.0b013e318181e6af.","journal-title":"Med (Baltim)"},{"issue":"10","key":"3538_CR38","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s00296-009-1152-8","volume":"30","author":"V Yazisiz","year":"2010","unstructured":"Yazisiz V, Arslan G, Ozbudak IH, et al. Lung involvement in patients with primary Sj\u00f6gren\u2019s syndrome: what are the predictors? Rheumatol Int. 2010;30(10):1317\u201324. https:\/\/doi.org\/10.1007\/s00296-009-1152-8.","journal-title":"Rheumatol Int"},{"issue":"4","key":"3538_CR39","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/00005382-200110000-00009","volume":"16","author":"M Uffmann","year":"2001","unstructured":"Uffmann M, Kiener HP, Bankier AA, Baldt MM, Zontsich T, Herold CJ. Lung manifestation in asymptomatic patients with primary Sj\u00f6gren syndrome: assessment with high resolution CT and pulmonary function tests. J Thorac Imaging. 2001;16(4):282\u20139. https:\/\/doi.org\/10.1097\/00005382-200110000-00009.","journal-title":"J Thorac Imaging"},{"issue":"5","key":"3538_CR40","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1183\/13993003.00829-2015","volume":"47","author":"P Spagnolo","year":"2016","unstructured":"Spagnolo P, Cordier JF, Cottin V. Connective tissue diseases, Multimorbidity and the ageing lung. Eur Respir J. 2016;47(5):1535\u201358. https:\/\/doi.org\/10.1183\/13993003.00829-2015.","journal-title":"Eur Respir J"},{"issue":"1","key":"3538_CR41","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12890-019-0875-x","volume":"19","author":"A Manfredi","year":"2019","unstructured":"Manfredi A, Cassone G, Cerri S, et al. Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: the inspirate validation study (INterStitial pneumonia in rheumatoid arthritis with an electronic device). BMC Pulm Med. 2019;19(1):111. https:\/\/doi.org\/10.1186\/s12890-019-0875-x.","journal-title":"BMC Pulm Med"},{"issue":"1","key":"3538_CR42","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12890-018-0670-0","volume":"18","author":"G Sgalla","year":"2018","unstructured":"Sgalla G, Walsh SLF, Sverzellati N, et al. Velcro-type crackles predict specific radiologic features of fibrotic interstitial lung disease. BMC Pulm Med. 2018;18(1):103. https:\/\/doi.org\/10.1186\/s12890-018-0670-0.","journal-title":"BMC Pulm Med"},{"key":"3538_CR43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.compbiomed.2018.03.006","volume":"96","author":"F Pancaldi","year":"2018","unstructured":"Pancaldi F, Sebastiani M, Cassone G, et al. Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis. Comput Biol Med. 2018;96:91\u20137. https:\/\/doi.org\/10.1016\/j.compbiomed.2018.03.006.","journal-title":"Comput Biol Med"},{"issue":"1","key":"3538_CR44","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s12931-024-02979-9","volume":"25","author":"G Sgalla","year":"2024","unstructured":"Sgalla G, Simonetti J, Di Bartolomeo A, et al. Reliability of crackles in fibrotic interstitial lung disease: a prospective, longitudinal study. Respir Res. 2024;25(1):352. https:\/\/doi.org\/10.1186\/s12931-024-02979-9.","journal-title":"Respir Res"},{"issue":"11","key":"3538_CR45","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1513\/AnnalsATS.202112-1377RL","volume":"19","author":"S Ghodrati","year":"2022","unstructured":"Ghodrati S, Pugashetti JV, Kadoch MA, Ghasemiesfe A, Oldham JM. Diagnostic accuracy of chest radiography for detecting fibrotic interstitial lung disease. Ann Am Thorac Soc. 2022;19(11):1934\u20137. https:\/\/doi.org\/10.1513\/AnnalsATS.202112-1377RL.","journal-title":"Ann Am Thorac Soc"},{"issue":"6","key":"3538_CR46","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1164\/rccm.200403-417OC","volume":"171","author":"I Ito","year":"2005","unstructured":"Ito I, Nagai S, Kitaichi M, et al. Pulmonary manifestations of primary Sj\u00f6gren\u2019s syndrome: A clinical, radiologic, and pathologic study. Am J Respir Crit Care Med. 2005;171(6):632\u20138. https:\/\/doi.org\/10.1164\/rccm.200403-417OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"157","key":"3538_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1183\/16000617.0021-2020","volume":"29","author":"F Luppi","year":"2020","unstructured":"Luppi F, Sebastiani M, Sverzellati N, Cavazza A, Salvarani C, Manfredi A. Lung complications of Sjogren syndrome. Eur Respir Rev. 2020;29(157):1\u201317. https:\/\/doi.org\/10.1183\/16000617.0021-2020.","journal-title":"Eur Respir Rev"},{"issue":"1","key":"3538_CR48","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/ard.58.1.61","volume":"58","author":"SA Papiris","year":"1999","unstructured":"Papiris SA, Maniati M, Constantopoulos SH, Roussos C, Moutsopoulos HM, Skopouli FN. Lung involvement in primary Sj\u00f6gren\u2019s syndrome is mainly related to the small airway disease. Ann Rheum Dis. 1999;58(1):61\u20134. https:\/\/doi.org\/10.1136\/ard.58.1.61.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3538_CR49","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1136\/thx.46.3.180","volume":"46","author":"C Kelly","year":"1991","unstructured":"Kelly C, Gardiner P, Pal B, Griffiths I. Lung function in primary Sj\u00f6gren\u2019s syndrome: a cross sectional and longitudinal study. Thorax. 1991;46(3):180\u20133. https:\/\/doi.org\/10.1136\/thx.46.3.180.","journal-title":"Thorax"},{"issue":"2","key":"3538_CR50","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1164\/rccm.201112-2160CI","volume":"186","author":"JMB Hughes","year":"2012","unstructured":"Hughes JMB, Pride NB. Examination of the carbon monoxide diffusing capacity (DL(CO)) in relation to its KCO and VA components. Am J Respir Crit Care Med. 2012;186(2):132\u20139. https:\/\/doi.org\/10.1164\/rccm.201112-2160CI.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3538_CR51","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/art.30077","volume":"63","author":"V Cottin","year":"2011","unstructured":"Cottin V, Nunes H, Mouthon L, et al. Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease. Arthritis Rheum. 2011;63(1):295\u2013304. https:\/\/doi.org\/10.1002\/art.30077.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3538_CR52","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1378\/chest.08-2306","volume":"136","author":"M Mej\u00eda","year":"2009","unstructured":"Mej\u00eda M, Carrillo G, Rojas-Serrano J, et al. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest. 2009;136(1):10\u20135. https:\/\/doi.org\/10.1378\/chest.08-2306.","journal-title":"Chest"},{"issue":"5","key":"3538_CR53","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1378\/chest.130.5.1489","volume":"130","author":"JG Parambil","year":"2006","unstructured":"Parambil JG, Myers JL, Lindell RM, Matteson EL, Ryu JH. Interstitial lung disease in primary Sj\u00f6gren syndrome. Chest. 2006;130(5):1489\u201395. https:\/\/doi.org\/10.1378\/chest.130.5.1489.","journal-title":"Chest"},{"issue":"7","key":"3538_CR54","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1164\/rccm.202505-1054ST","volume":"211","author":"AJ Podolanczuk","year":"2025","unstructured":"Podolanczuk AJ, Hunninghake GM, Wilson KC, et al. Approach to the evaluation and management of interstitial lung abnormalities: an official American thoracic society clinical statement. Am J Respir Crit Care Med. 2025;211(7):1132\u201355. https:\/\/doi.org\/10.1164\/rccm.202505-1054ST.","journal-title":"Am J Respir Crit Care Med"},{"key":"3538_CR55","doi-asserted-by":"publisher","unstructured":"Joy GM, Arbiv OA, Wong CK, et al. Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis. Eur Respir Rev. 2023;32(167). https:\/\/doi.org\/10.1183\/16000617.0210-2022.","DOI":"10.1183\/16000617.0210-2022"},{"issue":"1","key":"3538_CR56","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.medcli.2017.06.066","volume":"150","author":"J Mart\u00ednez-Barrio","year":"2018","unstructured":"Mart\u00ednez-Barrio J, Valor L, L\u00f3pez-Longo FJ. Facts and controversies in mixed connective tissue disease. Med Clin (Barc). 2018;150(1):26\u201332. https:\/\/doi.org\/10.1016\/j.medcli.2017.06.066.","journal-title":"Med Clin (Barc)"},{"key":"3538_CR57","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jaut.2014.01.008","volume":"48\u201349","author":"C Tani","year":"2014","unstructured":"Tani C, Carli L, Vagnani S, et al. The diagnosis and classification of mixed connective tissue disease. J Autoimmun. 2014;48\u201349:46\u20139. https:\/\/doi.org\/10.1016\/j.jaut.2014.01.008.","journal-title":"J Autoimmun"},{"issue":"1","key":"3538_CR58","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.berh.2016.03.002","volume":"30","author":"R Gunnarsson","year":"2016","unstructured":"Gunnarsson R, Hetlevik SO, Lilleby V, Molberg \u00d8. Mixed connective tissue disease. Best Pract Res Clin Rheumatol. 2016;30(1):95\u2013111. https:\/\/doi.org\/10.1016\/j.berh.2016.03.002.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"3538_CR59","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1191\/0961203306lu2283rr","volume":"15","author":"PJW Venables","year":"2006","unstructured":"Venables PJW. Mixed connective tissue disease. Lupus. 2006;15(3):132\u20137. https:\/\/doi.org\/10.1191\/0961203306lu2283rr.","journal-title":"Lupus"},{"issue":"4","key":"3538_CR60","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/joim.13752","volume":"295","author":"K Chevalier","year":"2024","unstructured":"Chevalier K, Thoreau B, Michel M, et al. Clinical presentation, course, and prognosis of patients with mixed connective tissue disease: A multicenter retrospective cohort. J Intern Med. 2024;295(4):532\u201343. https:\/\/doi.org\/10.1111\/joim.13752.","journal-title":"J Intern Med"},{"issue":"4","key":"3538_CR61","doi-asserted-by":"publisher","first-page":"103513","DOI":"10.1016\/j.autrev.2023.103513","volume":"23","author":"A Terminiello","year":"2024","unstructured":"Terminiello A, Marrani E, Pagnini I, et al. Childhood mixed connective tissue disease at disease onset: evidence from a systematic review. Autoimmun Rev. 2024;23(4):103513. https:\/\/doi.org\/10.1016\/j.autrev.2023.103513.","journal-title":"Autoimmun Rev"},{"issue":"5","key":"3538_CR62","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/rheumatology\/keh575","volume":"44","author":"E Bodolay","year":"2005","unstructured":"Bodolay E, Szekanecz Z, D\u00e9v\u00e9nyi K, et al. Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD). Rheumatology (Oxford). 2005;44(5):656\u201361. https:\/\/doi.org\/10.1093\/rheumatology\/keh575.","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"3538_CR63","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1136\/annrheumdis-2011-201253","volume":"71","author":"R Gunnarsson","year":"2012","unstructured":"Gunnarsson R, Aal\u00f8kken TM, Molberg \u00d8, et al. Prevalence and severity of interstitial lung disease in mixed connective tissue disease: a nationwide, cross-sectional study. Ann Rheum Dis. 2012;71(12):1966\u201372. https:\/\/doi.org\/10.1136\/annrheumdis-2011-201253.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3538_CR64","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1055\/s-2007-985611","volume":"28","author":"A Devaraj","year":"2007","unstructured":"Devaraj A, Wells AU, Hansell DM. Computed tomographic imaging in connective tissue diseases. Semin Respir Crit Care Med. 2007;28(4):389\u201397. https:\/\/doi.org\/10.1055\/s-2007-985611.","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"3538_CR65","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/00005382-200104000-00005","volume":"16","author":"T Kozuka","year":"2001","unstructured":"Kozuka T, Johkoh T, Honda O, et al. Pulmonary involvement in mixed connective tissue disease: high-resolution CT findings in 41 patients. J Thorac Imaging. 2001;16(2):94\u20138. https:\/\/doi.org\/10.1097\/00005382-200104000-00005.","journal-title":"J Thorac Imaging"},{"issue":"5","key":"3538_CR66","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1080\/03009740600844381","volume":"35","author":"A Afeltra","year":"2006","unstructured":"Afeltra A, Zennaro D, Garzia P, et al. Prevalence of interstitial lung involvement in patients with connective tissue diseases assessed with high-resolution computed tomography. Scand J Rheumatol. 2006;35(5):388\u201394. https:\/\/doi.org\/10.1080\/03009740600844381.","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"3538_CR67","first-page":"648","volume":"36","author":"N Narula","year":"2018","unstructured":"Narula N, Narula T, Mira-Avendano I, Wang B, Abril A. Interstitial lung disease in patients with mixed connective tissue disease: pilot study on predictors of lung involvement. Clin Exp Rheumatol. 2018;36(4):648\u201351.","journal-title":"Clin Exp Rheumatol"},{"key":"3538_CR68","doi-asserted-by":"publisher","first-page":"152258","DOI":"10.1016\/j.semarthrit.2023.152258","volume":"63","author":"G Boleto","year":"2023","unstructured":"Boleto G, Reiseter S, Hoffmann-Vold AM, et al. The phenotype of mixed connective tissue disease patients having associated interstitial lung disease. Semin Arthritis Rheum. 2023;63:152258. https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152258.","journal-title":"Semin Arthritis Rheum"},{"issue":"23","key":"3538_CR69","doi-asserted-by":"publisher","first-page":"7481","DOI":"10.3390\/jcm12237481","volume":"12","author":"M Silv\u00e9rio-Ant\u00f3nio","year":"2023","unstructured":"Silv\u00e9rio-Ant\u00f3nio M, Martins-Martinho J, Melo AT, et al. Predictors of interstitial lung disease in mixed connective tissue disease. J Clin Med. 2023;12(23):7481. https:\/\/doi.org\/10.3390\/jcm12237481.","journal-title":"J Clin Med"},{"issue":"6","key":"3538_CR70","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.rmed.2008.12.018","volume":"103","author":"MN Fagundes","year":"2009","unstructured":"Fagundes MN, Caleiro MTC, Navarro-Rodriguez T, et al. Esophageal involvement and interstitial lung disease in mixed connective tissue disease. Respir Med. 2009;103(6):854\u201360. https:\/\/doi.org\/10.1016\/j.rmed.2008.12.018.","journal-title":"Respir Med"},{"issue":"2","key":"3538_CR71","doi-asserted-by":"publisher","first-page":"297","DOI":"10.5114\/aoms.2018.81129","volume":"16","author":"M Celi\u0144ska-L\u00f6wenhoff","year":"2020","unstructured":"Celi\u0144ska-L\u00f6wenhoff M, Pastuszczak M, Pe\u0142ka K, Stec-Polak M, Wojas-Pelc A, Musia\u0142 J. Associations between nailfold capillaroscopy findings and interstitial lung disease in patients with mixed connective tissue disease. Arch Med Sci. 2020;16(2):297\u2013301. https:\/\/doi.org\/10.5114\/aoms.2018.81129.","journal-title":"Arch Med Sci"},{"issue":"13","key":"3538_CR72","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1177\/0961203312456751","volume":"21","author":"P Szodoray","year":"2012","unstructured":"Szodoray P, Hajas A, Kardos L, et al. Distinct phenotypes in mixed connective tissue disease: subgroups and survival. Lupus. 2012;21(13):1412\u201322. https:\/\/doi.org\/10.1177\/0961203312456751.","journal-title":"Lupus"},{"issue":"3","key":"3538_CR73","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/RHU.0000000000000500","volume":"23","author":"L Escol\u00e0-Verg\u00e9","year":"2017","unstructured":"Escol\u00e0-Verg\u00e9 L, Pinal-Fernandez I, Fernandez-Codina A, et al. Mixed connective tissue disease and epitope spreading: an historical cohort study. J Clin Rheumatol. 2017;23(3):155\u20139. https:\/\/doi.org\/10.1097\/RHU.0000000000000500.","journal-title":"J Clin Rheumatol"},{"issue":"167","key":"3538_CR74","doi-asserted-by":"publisher","first-page":"220210","DOI":"10.1183\/16000617.0210-2022","volume":"32","author":"GM Joy","year":"2023","unstructured":"Joy GM, Arbiv OA, Wong CK, et al. Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis. Eur Respir Rev. 2023;32(167):220210. https:\/\/doi.org\/10.1183\/16000617.0210-2022.","journal-title":"Eur Respir Rev"},{"issue":"2","key":"3538_CR75","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/rheumatology\/kex077","volume":"57","author":"S Reiseter","year":"2018","unstructured":"Reiseter S, Gunnarsson R, Mogens Aal\u00f8kken T, et al. Progression and mortality of interstitial lung disease in mixed connective tissue disease: a long-term observational nationwide cohort study. Rheumatology (Oxford). 2018;57(2):255\u201362. https:\/\/doi.org\/10.1093\/rheumatology\/kex077.","journal-title":"Rheumatology (Oxford)"},{"issue":"28","key":"3538_CR76","doi-asserted-by":"publisher","first-page":"e43299","DOI":"10.1097\/MD.0000000000043299","volume":"104","author":"Y Liu","year":"2025","unstructured":"Liu Y, Xu S, Shi C, Yang Q. KL-6, IL-18, and S100A8\/A9 are biomarkers of connective tissue disease-associated interstitial lung disease. Med (Baltim). 2025;104(28):e43299. https:\/\/doi.org\/10.1097\/MD.0000000000043299.","journal-title":"Med (Baltim)"},{"key":"3538_CR77","doi-asserted-by":"publisher","first-page":"120473","DOI":"10.1016\/j.cca.2025.120473","volume":"577","author":"CC Tzang","year":"2025","unstructured":"Tzang CC, Lin WC, Huang ES, et al. Interstitial lung disease biomarkers: a systematic review and meta-analysis. Clin Chim Acta. 2025;577:120473. https:\/\/doi.org\/10.1016\/j.cca.2025.120473.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"3538_CR78","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3390\/ijms26031091","volume":"26","author":"E Mi\u0105dlikowska","year":"2025","unstructured":"Mi\u0105dlikowska E, Mi\u0142kowska-Dymanowska J, Bia\u0142as AJ, et al. Serum KL-6 and SP-D: markers of lung function in autoimmune-related interstitial lung diseases. Int J Mol Sci. 2025;26(3):1091. https:\/\/doi.org\/10.3390\/ijms26031091.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3538_CR79","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.semarthrit.2020.01.006","volume":"50","author":"M Elhai","year":"2020","unstructured":"Elhai M, Avouac J, Allanore Y. Circulating lung biomarkers in idiopathic lung fibrosis and interstitial lung diseases associated with connective tissue diseases: where do we stand? Semin Arthritis Rheum. 2020;50(3):480\u201391. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.01.006.","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"3538_CR80","doi-asserted-by":"publisher","first-page":"e0241719","DOI":"10.1371\/journal.pone.0241719","volume":"15","author":"M Kameda","year":"2020","unstructured":"Kameda M, Otsuka M, Chiba H, et al. CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features. PLoS ONE. 2020;15(11):e0241719. https:\/\/doi.org\/10.1371\/journal.pone.0241719.","journal-title":"PLoS ONE"},{"key":"3538_CR81","doi-asserted-by":"publisher","first-page":"1390642","DOI":"10.3389\/fimmu.2024.1390642","volume":"15","author":"S Nicola","year":"2024","unstructured":"Nicola S, Borrelli R, Corradi F, et al. Relationship between clinical manifestations and serological profile in patients affected by systemic lupus erythematosus. Front Immunol. 2024;15:1390642. https:\/\/doi.org\/10.3389\/fimmu.2024.1390642.","journal-title":"Front Immunol"},{"issue":"17","key":"3538_CR82","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1001\/jama.2024.2315","volume":"331","author":"CH Siegel","year":"2024","unstructured":"Siegel CH, Sammaritano LR. Systemic lupus erythematosus: a review. JAMA. 2024;331(17):1480\u201391. https:\/\/doi.org\/10.1001\/jama.2024.2315.","journal-title":"JAMA"},{"issue":"14","key":"3538_CR83","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1177\/09612033241292162","volume":"33","author":"F Saliba","year":"2024","unstructured":"Saliba F, Khattar G, Mourad O, et al. Evaluating the impact of type 2 diabetes mellitus on interstitial lung disease prevalence in patients with systemic lupus erythematosus: a national inpatient sample analysis. Lupus. 2024;33(14):1547\u201355. https:\/\/doi.org\/10.1177\/09612033241292162.","journal-title":"Lupus"},{"issue":"1","key":"3538_CR84","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s13075-018-1776-8","volume":"20","author":"J Narv\u00e1ez","year":"2018","unstructured":"Narv\u00e1ez J, Borrell H, S\u00e1nchez-Alonso F, et al. Primary respiratory disease in patients with systemic lupus erythematosus: data from the Spanish rheumatology society lupus registry (RELESSER) cohort. Arthritis Res Ther. 2018;20(1):280. https:\/\/doi.org\/10.1186\/s13075-018-1776-8.","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"3538_CR85","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/resp.14268","volume":"27","author":"A Mageau","year":"2022","unstructured":"Mageau A, Borie R, Crestani B, Timsit JF, Papo T, Sacre K. Epidemiology of interstitial lung disease in systemic lupus erythematosus in france: a nation-wide population-based study over 10 years. Respirology. 2022;27(8):630\u20134. https:\/\/doi.org\/10.1111\/resp.14268.","journal-title":"Respirology"},{"issue":"1","key":"3538_CR86","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/00004728-200001000-00003","volume":"24","author":"JS Kim","year":"2000","unstructured":"Kim JS, Lee KS, Koh EM, Kim SY, Chung MP, Han J. Thoracic involvement of systemic lupus erythematosus: clinical, pathologic, and radiologic findings. J Comput Assist Tomogr. 2000;24(1):9\u201318. https:\/\/doi.org\/10.1097\/00004728-200001000-00003.","journal-title":"J Comput Assist Tomogr"},{"key":"3538_CR87","doi-asserted-by":"publisher","unstructured":"Kim EA, Lee KS, Johkoh T, et al. Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings. Radiographics. 2002;22 Spec No:S151-165. https:\/\/doi.org\/10.1148\/radiographics.22.suppl_1.g02oc04s151.","DOI":"10.1148\/radiographics.22.suppl_1.g02oc04s151"},{"issue":"4","key":"3538_CR88","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.rcl.2024.12.001","volume":"63","author":"K Kuykendall","year":"2025","unstructured":"Kuykendall K, Raptis C, Bhalla S. Interstitial lung disease in connective tissue disease. Radiol Clin North Am. 2025;63(4):595\u2013607. https:\/\/doi.org\/10.1016\/j.rcl.2024.12.001.","journal-title":"Radiol Clin North Am"},{"issue":"8","key":"3538_CR89","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/resp.14703","volume":"29","author":"L Deneuville","year":"2024","unstructured":"Deneuville L, Mageau A, Debray MP, et al. Chronic interstitial lung disease associated with systemic lupus erythematosus: a multicentric study of 89 cases. Respirology. 2024;29(8):713\u201321. https:\/\/doi.org\/10.1111\/resp.14703.","journal-title":"Respirology"},{"issue":"6","key":"3538_CR90","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.rcl.2016.05.005","volume":"54","author":"J Ahuja","year":"2016","unstructured":"Ahuja J, Arora D, Kanne JP, Henry TS, Godwin JD. Imaging of pulmonary manifestations of connective tissue diseases. Radiol Clin North Am. 2016;54(6):1015\u201331. https:\/\/doi.org\/10.1016\/j.rcl.2016.05.005.","journal-title":"Radiol Clin North Am"},{"issue":"1","key":"3538_CR91","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1177\/09612033231218957","volume":"33","author":"L Dans Vil\u00e1n","year":"2024","unstructured":"Dans Vil\u00e1n L, R\u00edos Fern\u00e1ndez R, Fern\u00e1ndez Ontiveros S, et al. Lymphoid interstitial pneumonia in a patient with systemic lupus erythematosus: case report and literature review. Lupus. 2024;33(1):83\u20137. https:\/\/doi.org\/10.1177\/09612033231218957.","journal-title":"Lupus"},{"issue":"1","key":"3538_CR92","doi-asserted-by":"publisher","first-page":"7355","DOI":"10.1038\/s41598-019-43782-7","volume":"9","author":"N Enomoto","year":"2019","unstructured":"Enomoto N, Egashira R, Tabata K, et al. Analysis of systemic lupus erythematosus-related interstitial pneumonia: a retrospective multicentre study. Sci Rep. 2019;9(1):7355. https:\/\/doi.org\/10.1038\/s41598-019-43782-7.","journal-title":"Sci Rep"},{"issue":"2","key":"3538_CR93","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.semarthrit.2018.01.010","volume":"48","author":"JL Medlin","year":"2018","unstructured":"Medlin JL, Hansen KE, McCoy SS, Bartels CM. Pulmonary manifestations in late versus early systemic lupus erythematosus: a systematic review and meta-analysis. Semin Arthritis Rheum. 2018;48(2):198\u2013204. https:\/\/doi.org\/10.1016\/j.semarthrit.2018.01.010.","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"3538_CR94","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1177\/09612033231182747","volume":"32","author":"Y Liu","year":"2023","unstructured":"Liu Y, Lu F, Liao H, Wang L, Lu P. Investigating the potential associated factors and developing a risk model for interstitial lung disease in Chinese patients with systemic lupus erythematosus. Lupus. 2023;32(8):993\u20131000. https:\/\/doi.org\/10.1177\/09612033231182747.","journal-title":"Lupus"},{"issue":"2","key":"3538_CR95","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1055\/s-0034-1371527","volume":"35","author":"F Bonella","year":"2014","unstructured":"Bonella F, Costabel U. Biomarkers in connective tissue disease-associated interstitial lung disease. Semin Respir Crit Care Med. 2014;35(2):181\u2013200. https:\/\/doi.org\/10.1055\/s-0034-1371527.","journal-title":"Semin Respir Crit Care Med"},{"issue":"12","key":"3538_CR96","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1177\/09612033221122158","volume":"31","author":"T Cotton","year":"2022","unstructured":"Cotton T, Fritzler MJ, Choi MY, et al. Serologic phenotypes distinguish systemic lupus erythematosus patients developing interstitial lung disease and\/or myositis. Lupus. 2022;31(12):1477\u201384. https:\/\/doi.org\/10.1177\/09612033221122158.","journal-title":"Lupus"},{"issue":"2","key":"3538_CR97","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1055\/s-0034-1371542","volume":"35","author":"F Lake","year":"2014","unstructured":"Lake F, Proudman S. Rheumatoid arthritis and lung disease: from mechanisms to a practical approach. Semin Respir Crit Care Med. 2014;35(2):222\u201338. https:\/\/doi.org\/10.1055\/s-0034-1371542.","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"3538_CR98","doi-asserted-by":"publisher","first-page":"2332406","DOI":"10.1080\/07853890.2024.2332406","volume":"56","author":"HF Wang","year":"2024","unstructured":"Wang HF, Wang YY, Li ZY, He PJ, Liu S, Li QS. The prevalence and risk factors of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis. Ann Med. 2024;56(1):2332406. https:\/\/doi.org\/10.1080\/07853890.2024.2332406.","journal-title":"Ann Med"},{"issue":"2","key":"3538_CR99","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1001\/archinternmed.2007.59","volume":"168","author":"BR Gochuico","year":"2008","unstructured":"Gochuico BR, Avila NA, Chow CK, et al. Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch Intern Med. 2008;168(2):159\u201366. https:\/\/doi.org\/10.1001\/archinternmed.2007.59.","journal-title":"Arch Intern Med"},{"issue":"10","key":"3538_CR100","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1136\/annrheumdis-2017-211138","volume":"76","author":"C Hyldgaard","year":"2017","unstructured":"Hyldgaard C, Hilberg O, Pedersen AB, et al. A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality. Ann Rheum Dis. 2017;76(10):1700\u20136. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211138.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"3538_CR101","doi-asserted-by":"publisher","first-page":"e851","DOI":"10.1016\/S2665-9913(25)00158-4","volume":"7","author":"GC McDermott","year":"2025","unstructured":"McDermott GC, Gill R, Byrne S, et al. Risk factors for interstitial lung disease in early rheumatoid arthritis and external validation of screening strategies: a cross-sectional analysis of the prospective SAIL-RA cohort in the USA. Lancet Rheumatol. 2025;7(12):e851\u201363. https:\/\/doi.org\/10.1016\/S2665-9913(25)00158-4.","journal-title":"Lancet Rheumatol"},{"issue":"23","key":"3538_CR102","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205\u201319. https:\/\/doi.org\/10.1056\/NEJMra1004965.","journal-title":"N Engl J Med"},{"issue":"23","key":"3538_CR103","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","volume":"379","author":"PA Juge","year":"2018","unstructured":"Juge PA, Lee JS, Ebstein E, et al. MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease. N Engl J Med. 2018;379(23):2209\u201319. https:\/\/doi.org\/10.1056\/NEJMoa1801562.","journal-title":"N Engl J Med"},{"issue":"10","key":"3538_CR104","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1136\/ard.2007.075192","volume":"67","author":"D Makrygiannakis","year":"2008","unstructured":"Makrygiannakis D, Hermansson M, Ulfgren AK, et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis. 2008;67(10):1488\u201392. https:\/\/doi.org\/10.1136\/ard.2007.075192.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"3538_CR105","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1183\/09031936.00092309","volume":"35","author":"EJ Kim","year":"2010","unstructured":"Kim EJ, Elicker BM, Maldonado F, et al. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J. 2010;35(6):1322\u20138. https:\/\/doi.org\/10.1183\/09031936.00092309.","journal-title":"Eur Respir J"},{"issue":"2","key":"3538_CR106","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1183\/13993003.00357-2015","volume":"47","author":"JJ Solomon","year":"2016","unstructured":"Solomon JJ, Chung JH, Cosgrove GP, et al. Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J. 2016;47(2):588\u201396. https:\/\/doi.org\/10.1183\/13993003.00357-2015.","journal-title":"Eur Respir J"},{"issue":"1","key":"3538_CR107","doi-asserted-by":"publisher","first-page":"e001817","DOI":"10.1136\/bmjresp-2023-001817","volume":"11","author":"C Yu","year":"2024","unstructured":"Yu C, Zhang Y, Jin S, et al. Risk factors for incidence of interstitial lung disease in patients with rheumatoid arthritis: a systematic review and meta-analysis. BMJ Open Respir Res. 2024;11(1):e001817. https:\/\/doi.org\/10.1136\/bmjresp-2023-001817.","journal-title":"BMJ Open Respir Res"},{"key":"3538_CR108","doi-asserted-by":"publisher","unstructured":"Zhang L, Wu G, Gao D, et al. Factors associated with interstitial lung disease in patients with polymyositis and dermatomyositis: a systematic review and meta-analysis. PLoS ONE. 2016;11(5). https:\/\/doi.org\/10.1371\/journal.pone.0155381.","DOI":"10.1371\/journal.pone.0155381"},{"issue":"9","key":"3538_CR109","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","volume":"53","author":"CA Kelly","year":"2014","unstructured":"Kelly CA, Saravanan V, Nisar M, et al. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics\u2013a large multicentre UK study. Rheumatology (Oxford). 2014;53(9):1676\u201382. https:\/\/doi.org\/10.1093\/rheumatology\/keu165.","journal-title":"Rheumatology (Oxford)"},{"key":"3538_CR110","doi-asserted-by":"publisher","unstructured":"Tekaya AB, Mokaddem S, Athimini S, Kamoun H, Mahmoud I, Abdelmoula L. Risk factors for rheumatoid arthritis-associated interstitial lung disease: A retrospective study. Multidisciplinary Respiratory Med. 2022;17. https:\/\/doi.org\/10.4081\/mrm.2022.877.","DOI":"10.4081\/mrm.2022.877"},{"issue":"2 Pt 1","key":"3538_CR111","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1164\/ajrccm.156.2.9609016","volume":"156","author":"E Gabbay","year":"1997","unstructured":"Gabbay E, Tarala R, Will R, et al. Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med. 1997;156(2 Pt 1):528\u201335. https:\/\/doi.org\/10.1164\/ajrccm.156.2.9609016.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"3538_CR112","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s00296-023-05313-6","volume":"43","author":"GM Koduri","year":"2023","unstructured":"Koduri GM, Podlasek A, Pattapola S, et al. Four-factor risk score for the prediction of interstitial lung disease in rheumatoid arthritis. Rheumatol Int. 2023;43(8):1515\u201323. https:\/\/doi.org\/10.1007\/s00296-023-05313-6.","journal-title":"Rheumatol Int"},{"issue":"12","key":"3538_CR113","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1164\/rccm.201411-1950OC","volume":"191","author":"TJ Doyle","year":"2015","unstructured":"Doyle TJ, Patel AS, Hatabu H, et al. Detection of rheumatoid Arthritis-Interstitial lung disease is enhanced by serum biomarkers. Am J Respir Crit Care Med. 2015;191(12):1403\u201312. https:\/\/doi.org\/10.1164\/rccm.201411-1950OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3538_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1\u201311. https:\/\/doi.org\/10.1002\/art.37715.","journal-title":"Arthritis Rheum"},{"key":"3538_CR115","doi-asserted-by":"publisher","unstructured":"Nada AK, Torres VE, Ryu JH, Lie JT, Holley KE. Pulmonary fibrosis as an unusual clinical manifestation of a pulmonary-renal vasculitis in elderly patients. Mayo Clin Proc. 1990;65(6):847\u2013856. https:\/\/doi.org\/10.1016\/s0025-6196(12)62575-0.","DOI":"10.1016\/s0025-6196(12)62575-0"},{"issue":"1","key":"3538_CR116","first-page":"46","volume":"35","author":"Y Arimura","year":"1995","unstructured":"Arimura Y, Minoshima S, Tanaka U, et al. Pulmonary involvement in patients with myeloperoxidase specific-antineutrophil cytoplasmic antibody. Ryumachi. 1995;35(1):46\u201355.","journal-title":"Ryumachi"},{"issue":"4","key":"3538_CR117","doi-asserted-by":"publisher","first-page":"553","DOI":"10.55563\/clinexprheumatol\/oyqz1p","volume":"43","author":"P Delvino","year":"2025","unstructured":"Delvino P, Baldini C, Bonacini M, et al. Systemic vasculitis: one year in review 2025. Clin Exp Rheumatol. 2025;43(4):553\u201362. https:\/\/doi.org\/10.55563\/clinexprheumatol\/oyqz1p.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"3538_CR118","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s10067-022-06388-5","volume":"42","author":"K Yamaguchi","year":"2023","unstructured":"Yamaguchi K, Yamaguchi A, Ito M, et al. Clinical differences among patients with myeloperoxidase\u2013antineutrophil cytoplasmic antibody\u2013positive interstitial lung disease. Clin Rheumatol. 2023;42(2):479\u201388. https:\/\/doi.org\/10.1007\/s10067-022-06388-5.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"3538_CR119","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1016\/j.chest.2021.01.083","volume":"159","author":"H Hozumi","year":"2021","unstructured":"Hozumi H, Kono M, Hasegawa H, et al. Clinical significance of interstitial lung disease and its acute exacerbation in microscopic polyangiitis. Chest. 2021;159(6):2334\u201345. https:\/\/doi.org\/10.1016\/j.chest.2021.01.083.","journal-title":"Chest"},{"issue":"11","key":"3538_CR120","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1093\/rheumatology\/ker236","volume":"50","author":"N Arulkumaran","year":"2011","unstructured":"Arulkumaran N, Periselneris N, Gaskin G, et al. Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study. Rheumatology (Oxford). 2011;50(11):2035\u201343. https:\/\/doi.org\/10.1093\/rheumatology\/ker236.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"3538_CR121","doi-asserted-by":"publisher","first-page":"821","DOI":"10.55563\/clinexprheumatol\/xu4hmh","volume":"41","author":"A Manfredi","year":"2023","unstructured":"Manfredi A, Cassone G, Izzo R, et al. Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian society for rheumatology. Clin Exp Rheumatol. 2023;41(4):821\u20138. https:\/\/doi.org\/10.55563\/clinexprheumatol\/xu4hmh.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"3538_CR122","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/rheumatology\/keac339","volume":"62","author":"B Doliner","year":"2023","unstructured":"Doliner B, Rodriguez K, Montesi SB, Fu X, Sharma A, Wallace ZS. Interstitial lung disease in ANCA-associated vasculitis: associated factors, radiographic features and mortality. Rheumatology (Oxford). 2023;62(2):716\u201325. https:\/\/doi.org\/10.1093\/rheumatology\/keac339.","journal-title":"Rheumatology (Oxford)"},{"key":"3538_CR123","doi-asserted-by":"publisher","unstructured":"Maillet T, Goletto T, Beltramo G et al. Usual interstitial pneumonia in ANCA-associated vasculitis: A poor prognostic factor. J Autoimmun. 2020;106. https:\/\/doi.org\/10.1016\/j.jaut.2019.102338. ((Maillet T.; Bonnotte B.; Samson M.) Department of Internal Medicine and Clinical Immunology, CHU Dijon Bourgogne, Dijon, France).","DOI":"10.1016\/j.jaut.2019.102338"},{"issue":"24","key":"3538_CR124","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/MD.0000000000000217","volume":"93","author":"C Comarmond","year":"2014","unstructured":"Comarmond C, Crestani B, Tazi A, et al. Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: A series of 49 patients and review of the literature. Medicine. 2014;93(24):340\u20139. https:\/\/doi.org\/10.1097\/MD.0000000000000217.","journal-title":"Medicine"},{"key":"3538_CR125","doi-asserted-by":"publisher","unstructured":"Hozumi H, Oyama Y, Yasui H, et al. Clinical significance of myeloperoxidase-antineutrophil cytoplasmic antibody in idiopathic interstitial pneumonias. PLoS ONE. 2018;13(6). https:\/\/doi.org\/10.1371\/journal.pone.0199659.","DOI":"10.1371\/journal.pone.0199659"},{"key":"3538_CR126","doi-asserted-by":"publisher","unstructured":"Homma S, Usui Y, Suzuki A et al. Difference in chest HRCT findings in relation to ANCA subtypes in ANCA-associated vasculitis. Eur Respir J. 2019;54. https:\/\/doi.org\/10.1183\/13993003.congress-2019.OA5158. ((Homma S., sahomma@med.toho-u.ac.jp; Usui Y.; Suzuki A.; Sakamoto S.) Toho University, Graduate Shool of Medicine, Tokyo, Japan).","DOI":"10.1183\/13993003.congress-2019.OA5158"},{"key":"3538_CR127","doi-asserted-by":"publisher","first-page":"100823","DOI":"10.1016\/j.clinsp.2025.100823","volume":"80","author":"N Yu","year":"2025","unstructured":"Yu N, Yang S, Zang D, Xu L, Yan R, Yu X. The risk factors of anti-neutrophil cytoplasmic antibody-associated vasculitis-associated interstitial lung disease: a systematic review and meta-analysis. Clinics. 2025;80:100823. https:\/\/doi.org\/10.1016\/j.clinsp.2025.100823.","journal-title":"Clinics"},{"issue":"6","key":"3538_CR128","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1002\/art.22633","volume":"56","author":"J Birnbaum","year":"2007","unstructured":"Birnbaum J, Danoff S, Askin FB, Stone JH. Microscopic polyangiitis presenting as a pulmonary-muscle syndrome: is subclinical alveolar hemorrhage the mechanism of pulmonary fibrosis? Arthritis Rheum. 2007;56(6):2065\u201371. https:\/\/doi.org\/10.1002\/art.22633.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"3538_CR129","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/resp.12763","volume":"21","author":"C Hosoda","year":"2016","unstructured":"Hosoda C, Baba T, Hagiwara E, et al. Clinical features of usual interstitial pneumonia with anti-neutrophil cytoplasmic antibody in comparison with idiopathic pulmonary fibrosis. Respirology. 2016;21(5):920\u20136. https:\/\/doi.org\/10.1111\/resp.12763.","journal-title":"Respirology"},{"issue":"10","key":"3538_CR130","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.3899\/jrheum.190313","volume":"47","author":"R Lhote","year":"2020","unstructured":"Lhote R, Chilles M, Groh M, et al. Spectrum and prognosis of antineutrophil cytoplasmic Antibody-associated Vasculitis-related bronchiectasis: data from 61 patients. J Rheumatol. 2020;47(10):1522\u201331. https:\/\/doi.org\/10.3899\/jrheum.190313.","journal-title":"J Rheumatol"},{"issue":"6","key":"3538_CR131","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1183\/09031936.00148409","volume":"37","author":"P Guilpain","year":"2011","unstructured":"Guilpain P, Ch\u00e9reau C, Goulvestre C, et al. The oxidation induced by antimyeloperoxidase antibodies triggers fibrosis in microscopic polyangiitis. Eur Respir J. 2011;37(6):1503\u201313. https:\/\/doi.org\/10.1183\/09031936.00148409.","journal-title":"Eur Respir J"},{"issue":"6","key":"3538_CR132","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nm.1959","volume":"15","author":"K Kessenbrock","year":"2009","unstructured":"Kessenbrock K, Krumbholz M, Sch\u00f6nermarck U, et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med. 2009;15(6):623\u20135. https:\/\/doi.org\/10.1038\/nm.1959.","journal-title":"Nat Med"},{"issue":"3","key":"3538_CR133","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/path.4359","volume":"233","author":"A Chrysanthopoulou","year":"2014","unstructured":"Chrysanthopoulou A, Mitroulis I, Apostolidou E, et al. Neutrophil extracellular traps promote differentiation and function of fibroblasts. J Pathol. 2014;233(3):294\u2013307. https:\/\/doi.org\/10.1002\/path.4359.","journal-title":"J Pathol"},{"issue":"8","key":"3538_CR134","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3899\/jrheum.220123","volume":"49","author":"S Matsuda","year":"2022","unstructured":"Matsuda S, Kotani T, Kuwabara H, et al. Association of M2 Macrophages, Th2, and B cells with pathomechanism in microscopic polyangiitis complicated by interstitial lung disease. J Rheumatol. 2022;49(8):913\u201321. https:\/\/doi.org\/10.3899\/jrheum.220123.","journal-title":"J Rheumatol"},{"issue":"8","key":"3538_CR135","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1136\/annrheumdis-2018-214263","volume":"78","author":"N Namba","year":"2019","unstructured":"Namba N, Kawasaki A, Sada KE, et al. Association of MUC5B promoter polymorphism with interstitial lung disease in myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis. Ann Rheum Dis. 2019;78(8):1144\u20136. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214263.","journal-title":"Ann Rheum Dis"},{"issue":"Supplement1","key":"3538_CR136","doi-asserted-by":"publisher","first-page":"i42","DOI":"10.1093\/rheumatology\/keae557","volume":"64","author":"U Specks","year":"2025","unstructured":"Specks U, Marty PK. Interstitial lung disease, antineutrophil cystoplasmic antibodies and microscopic polyangiitis. Rheumatology (Oxford). 2025;64(Supplement1):i42\u20137. https:\/\/doi.org\/10.1093\/rheumatology\/keae557.","journal-title":"Rheumatology (Oxford)"},{"key":"3538_CR137","doi-asserted-by":"publisher","unstructured":"Zhou P, Ma J, Wang G. Impact of interstitial lung disease on mortality in ANCA-associated vasculitis: a systematic literature review and meta-analysis. Chronic Respir Dis. 2021;18. https:\/\/doi.org\/10.1177\/1479973121994562 ((Zhou P.; Ma J., majjmail@163.com; Wang G.) Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, China).","DOI":"10.1177\/1479973121994562"},{"issue":"3","key":"3538_CR138","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10067-021-05964-5","volume":"41","author":"S Yang","year":"2022","unstructured":"Yang S, Chai D, Li Y, et al. Patterns of lung diseases predict survival in patients with MPO-ANCA-associated vasculitis: a single-center retrospective study. Clin Rheumatol. 2022;41(3):783\u201393. https:\/\/doi.org\/10.1007\/s10067-021-05964-5.","journal-title":"Clin Rheumatol"},{"key":"3538_CR139","doi-asserted-by":"publisher","unstructured":"Sun X, Peng M, Zhang T, et al. Clinical features and long-term outcomes of interstitial lung disease with anti-neutrophil cytoplasmic antibody. BMC Pulm Med. 2021;21(1). https:\/\/doi.org\/10.1186\/s12890-021-01451-4.","DOI":"10.1186\/s12890-021-01451-4"},{"issue":"4","key":"3538_CR140","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1183\/13993003.00150-2015","volume":"46","author":"A Fischer","year":"2015","unstructured":"Fischer A, Antoniou KM, Brown KK, et al. An official European respiratory society\/American thoracic society research statement: interstitial pneumonia with autoimmune features. Eur Respir J. 2015;46(4):976\u201387. https:\/\/doi.org\/10.1183\/13993003.00150-2015.","journal-title":"Eur Respir J"},{"issue":"5","key":"3538_CR141","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL, et al. Diagnosis of idiopathic pulmonary Fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198(5):e44\u201368. https:\/\/doi.org\/10.1164\/rccm.201807-1255ST.","journal-title":"Am J Respir Crit Care Med"},{"issue":"SUPPL 1","key":"3538_CR142","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1136\/annrheumdis-2020-eular.219","volume":"79","author":"S Moiseev","year":"2020","unstructured":"Moiseev S, Cohen Tervaert JW, Arimura Y, et al. International consensus on ANCA testing and interpretation beyond systemic vasculitis. Ann Rheum Dis. 2020;79(SUPPL 1):1553. https:\/\/doi.org\/10.1136\/annrheumdis-2020-eular.219.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3538_CR143","doi-asserted-by":"publisher","first-page":"e000058","DOI":"10.1136\/bmjresp-2014-000058","volume":"2","author":"N Kagiyama","year":"2015","unstructured":"Kagiyama N, Takayanagi N, Kanauchi T, Ishiguro T, Yanagisawa T, Sugita Y. Antineutrophil cytoplasmic antibody-positive conversion and microscopic polyangiitis development in patients with idiopathic pulmonary fibrosis. BMJ Open Respir Res. 2015;2(1):e000058. https:\/\/doi.org\/10.1136\/bmjresp-2014-000058.","journal-title":"BMJ Open Respir Res"},{"issue":"4","key":"3538_CR144","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.chest.2019.05.014","volume":"156","author":"GY Liu","year":"2019","unstructured":"Liu GY, Ventura IB, Achtar-Zadeh N, et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in North American patients with idiopathic pulmonary fibrosis. Chest. 2019;156(4):715\u201323. https:\/\/doi.org\/10.1016\/j.chest.2019.05.014.","journal-title":"Chest"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-026-03538-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03538-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03538-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:38:08Z","timestamp":1781631488000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12931-026-03538-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":144,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3538"],"URL":"https:\/\/doi.org\/10.1186\/s12931-026-03538-0","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}